Journal of Medicinal Chemistry p. 94 - 97 (1984)
Update date:2022-08-11
Topics:
Knapp, F. F.
Goodman, M. M.
Kabalka, G. W.
Sastry, K. A. R.
125I-labeled (E)-18-iodo-17-octadecenoic acid (13) has been prepared and evaluated in rats to determine the myocardial uptake and retention and degree of in vivo deiodination of this model iodovinyl-substituted fatty acid, which contains no structural perturbation to inhibit metabolism.This new agent was prepared by NaI-chloramine-T treatment of (17-carbomethoxyheptadec-1-en-1-yl)boronic acid (11) prepared by catecholborane treatment of methyl 17-octadecynoate (10), followed by basic hydrolysis to the free acid (13).The pivotal substrate, 17-octadecynoic acid (9), was prepared by two new routes .The 125I-labeled acid 13 showed high myocardial uptake (1 h, 1.90-2.28percent dose/g) with 45percent washout after 2 h but lower heart/blood ratios in comparison to analogues containing the tellurium heteroatom.Deiodination was low for the first 2 h after injection (2 h, 61percent dose/g).Excellent myocardial images were obtained in a dog with the 123I-labeled agent.
View MoreContact:0086 533 2282832
Address:Zibo,Shandong
Contact:86-575-86132822,86-575-86085355
Address:No.418 Dadao West Road,Qixing Street,Xinchang, Zhejiang Province, China.
Contact:+86 18616952870
Address:Area
Contact:86-571-86737118-8689
Address:No.69, 12 Street, HEDA, Hangzhou, Zhejiang, China
Contact:+49-9398-993127
Address:Untertorstr. 27
Doi:10.1039/P29860001269
(1986)Doi:10.1007/s10600-012-0288-z
(2012)Doi:10.1016/j.ejmech.2018.10.045
(2019)Doi:10.1071/CH00083
(2000)Doi:10.1006/jcat.2001.3437
(2002)Doi:10.1021/ol051517o
(2005)